Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Thursday, 16 November 2017

Orphazyme A/S: Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Orphazymes' shares

Orphazyme A/S    

Published: 10:30 CET 16-11-2017 /GlobeNewswire /Source: Orphazyme A/S / : ORPHA /ISIN: DK0060911055

Orphazyme A/S: Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Orphazymes' shares

Company announcement

Orphazyme A/S

No. 9/2017

Ole Maaløes Vej 3

 

DK-2200 Copenhagen N

 

 

 

www.orphazyme.com

 

Company Registration No. 32266355

 

 

 

16 November 2017

 

Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 ("Orphazyme"), hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in Orphazyme and persons closely associated with them in Orphazymes' shares in connection with the Initial Public Offering:

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Georges Gemayel

2

Reason for the notification

a)

Position/status

Chairman of the Board of Directors

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060910917

b)

Nature of the transaction

Exercise of warrants for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

1.00

87,758

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Bo Jesper Hansen

2

Reason for the notification

a)

Position/status

Deputy Chairman of the Board of Directors

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060910917

b)

Nature of the transaction

Exercise of warrants for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

1.00

29,445

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Bo Jesper Hansen

2

Reason for the notification

a)

Position/status

Deputy Chairman of the Board of Directors

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060911055

b)

Nature of the transaction

Subscription for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

80.00

50,000

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Bohrs Tower IVS

2

Reason for the notification

a)

Position/status

Closely Associated Person to Martin Bonde, member of the board of directors

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060910917

b)

Nature of the transaction

Exercise of warrants for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

1.00

42,884

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Martin Bonde

2

Reason for the notification

a)

Position/status

Member of the Board of Directors

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060911055

b)

Nature of the transaction

Subscription for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

80.00

3,125

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Rahbek Kornum IVS

2

Reason for the notification

a)

Position/status

Closely Associated Person to Martin Rahbek Kornum, member of the Board of Directors (resigned 16 November 2017)

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060910917

b)

Nature of the transaction

Exercise of warrants for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

1.00

22,726

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Catherine Moukheibir

2

Reason for the notification

a)

Position/status

Member of the Board of Directors

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060911055

b)

Nature of the transaction

Subscription for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

80.00

7,980

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Anders Hedegaard

2

Reason for the notification

a)

Position/status

Member of the Board of Directors

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060911055

b)

Nature of the transaction

Subscription for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

80.00

6,250

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Kurma Biofund II

2

Reason for the notification

a)

Position/status

Closely Associated Person to Rémi Droller, member of the Board of Directors

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060911055

b)

Nature of the transaction

Subscription for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

80.00

139,578

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

LSP V Cöoperatieve U.A.

2

Reason for the notification

a)

Position/status

Closely Associated Person to Martijn Kleijwegt, member of the Board of Directors

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060911055

b)

Nature of the transaction

Subscription for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

80.00

279,157

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

WoB Holding IVS

2

Reason for the notification

a)

Position/status

Closely Associated Person to Anders Hinsby, Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares 

ISIN DK0060910917

b)

Nature of the transaction

Exercise of warrants for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

1.00

180,846

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Anders Hinsby

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060911055

b)

Nature of the transaction

Subscription for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

80.00

5,000

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Alpha Healthcare Investments ApS

2

Reason for the notification

a)

Position/status

Closely Associated Person to Anders Vadsholt, Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060910917

b)

Nature of the transaction

Exercise of warrants for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

1.00

121,556

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Anders Vadsholt

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060911055

b)

Nature of the transaction

Subscription for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

80.00

6,250

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Dare to Dream IVS

2

Reason for the notification

a)

Position/status

Closely Associated Person to Thomas Kirkegaard Jensen, Chief Scientific Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060910917

b)

Nature of the transaction

Exercise of warrants for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

1.00

156,535

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Thomas Kirkegaard Jensen

2

Reason for the notification

a)

Position/status

Chief Scientific Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060911055

b)

Nature of the transaction

Subscription for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

80.00

4,000

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Thomas Blaettler

2

Reason for the notification

a)

Position/status

Chief Medical Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060910917

b)

Nature of the transaction

Exercise of warrants for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

1.00

108,502

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1

Details of the Reporting Person / Closely Associated Person

a)

Name

Thomas Blaettler

2

Reason for the notification

a)

Position/status

Chief Medical Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orphazyme A/S

b)

LEI code

54930025OZD2GGSQ7L42

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Shares  

ISIN DK0060911055

b)

Nature of the transaction

Subscription for shares

c)

Price(s) and volume(s)

Price (s)

Volume(s)

80.00

1,875

d)

Aggregated information

  • Aggregated volume
  • Price
 

e)

Date of the transaction

2017-11-16 09:00 UTC+1

f)

Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

For additional information, please contact 

 

Orphazyme

 

Anders Vadsholt, CFO

+45 28 98 90 55

 



Orphazyme A/S - Reporting of transactions



This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of Nasdaq Corporate Solutions clients. Source: Orphazyme A/S, Ole Maaløes Vej 3, Copenhagen N 2200, Danmark
If you would like to unsubscribe and stop receiving these e-mails click here.